SCHEMBL30834044

SCHEMBL30834044

Cc1cc(N[C@H]2CCCC[C@H]2O)cnc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 3/20 0.47
HTR1A P08908 2/20 0.39
KDM4E B2RXH2 2/20 0.37
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
MEN1 O00255 1/20 0.36
NPC1 O15118 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
ATM Q13315 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
CNR1 P21554 2/20 0.35
IDH1 O75874 1/20 0.35
KCNH2 Q12809 2/20 0.35
NLRP3 Q96P20 1/20 0.35
ZAP70 P43403 1/20 0.35
SMO Q99835 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30833874 0.75 IL1B (0.45) SYKHTR1AKDM4EMEN1NPC1
SCHEMBL26943723 0.75 IL1B (0.45) SYKHTR1AKDM4EMEN1NPC1
SCHEMBL30833991 0.75 IL1B (0.45) SYKHTR1AKDM4EMEN1NPC1
SCHEMBL22068319 0.69 SYK (0.64) SYKKCNH2ZAP70
SCHEMBL23030353 0.68 SMN1; SMN2 (0.54) KDM4EALDH1A1LMNAHTTMEN1
SCHEMBL20194474 0.68 SMN1; SMN2 (0.49) SYKKDM4EALDH1A1LMNAHTT
SCHEMBL18415611 0.68 SMN1; SMN2 (0.49) SYKKDM4EALDH1A1LMNAHTT
SCHEMBL7793274 0.68 SMN1; SMN2 (0.49) SYKKDM4EALDH1A1LMNAHTT
SCHEMBL23004981 0.68 SMN1; SMN2 (0.54) KDM4EALDH1A1LMNAHTTMEN1
SCHEMBL23004986 0.67 HTR1A (0.51) SYKHTR1AKDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024094185-A1 NLRP3 INFLAMMASOME INHIBITOR AND USE THEREOF 药捷安康(南京)科技股份有限公司 2024-05-10 WO disclosed
CN-117986258-A NLRP3 inflammation corpuscle inhibitor and application thereof 药捷安康(南京)科技股份有限公司 2024-05-07 CN disclosed